Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Liu, Ming

Class:IdPerson:9653312
_displayNameLiu, Ming
_timestamp2019-07-11 15:00:55
created[InstanceEdit:9653311] Rothfels, Karen, 2019-07-11
firstnameMing
initialM
surnameLiu
(author)[LiteratureReference:9653307] Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice
[LiteratureReference:9817573] PDIA1/P4HB is required for efficient proinsulin maturation and ß cell health in response to diet induced obesity
[Change default viewing format]
No pathways have been reviewed or authored by Liu, Ming (9653312)